Fund Holdings — Paradigm Biocapital Advisors LP

Total Portfolio Value:
$5.34B
Total Bought:
$1.59B
Total Sold:
$2.26B
Net Transaction:
-$671.78M
Notable People:
Dr. Senai Nmn Asefaw
Securities
▲▼
SharesValue
Q1 2026
▲▼
Q2 2026
▲▼
Change
▲▼
Q1 2026
▲▼
Q2 2026
▲▼
Weight (%)
▲▼
Change
▲▼
Revolution Medicines, Inc.(RVMD)6,655,7036,361,323-294,380$647.27M$1.19B22.31%+$544.08M
NUVALENT INC5,324,4335,924,433+600,000$545.49M$731.67M13.70%+$186.18M
Edgewise Therapeutics, Inc.(EWTX)7,365,03810,215,455+2,850,417$232.00M$415.05M7.77%+$183.06M
Genmab A/S(GMAB)7,967,83613,133,131+5,165,295$213.78M$360.77M6.76%+$146.99M
Spyre Therapeutics, Inc.(SYRE)1,957,2663,840,778+1,883,512$98.72M$340.98M6.38%+$242.26M
APOGEE THERAPEUTICS INC1,348,2431,576,385+228,142$113.48M$209.23M3.92%+$95.75M
Oruka Therapeutics, Inc.(ORKA)2,320,3162,144,526-175,790$113.81M$204.09M3.82%+$90.28M
Tango Therapeutics, Inc.(TNGX)4,009,6796,357,523+2,347,844$83.88M$198.74M3.72%+$114.85M
Belite Bio, Inc(BLTE)1,114,7841,232,877+118,093$177.74M$189.84M3.55%+$12.10M
Erasca, Inc.(ERAS)10,392,7029,550,000-842,702$168.15M$174.96M3.28%+$6.80M
Tarsus Pharmaceuticals, Inc.(TARS)2,562,1542,775,649+213,495$179.74M$174.70M3.27%-$5.04M
Alnylam Pharmaceuticals, Inc.(ALNY)0480,000+480,000$0$144.49M2.71%+$144.49M
Insmed Incorporated(INSM)1,254,4881,325,977+71,489$205.13M$141.38M2.65%-$63.76M
MBX Biosciences, Inc.(MBX)02,508,015+2,508,015$0$138.44M2.59%+$138.44M
Vaxcyte, Inc.(PCVX)4,793,0202,127,852-2,665,168$278.52M$123.69M2.32%-$154.83M
Viridian Therapeutics, Inc.(VRDN)3,148,8936,723,788+3,574,895$61.59M$123.52M2.31%+$61.92M
OLEMA PHARMACEUTICALS INC8,020,5768,670,576+650,000$119.59M$108.47M2.03%-$11.12M
JADE BIOSCIENCES INC02,857,405+2,857,405$0$63.49M1.19%+$63.49M
Tyra Biosciences, Inc.(TYRA)2,054,9911,828,607-226,384$78.71M$58.41M1.09%-$20.30M
ASSEMBLY BIOSCIENCES INC665,2511,553,748+888,497$18.46M$42.70M0.80%+$24.24M
EYEPOINT INC3,142,4372,890,397-252,040$40.51M$41.33M0.77%+$826.7K
ACHIEVE LIFE SCIENCE INC04,951,856+4,951,856$0$32.34M0.61%+$32.34M
Vor Biopharma Inc.(VOR)1,750,0001,750,0000$31.22M$32.22M0.60%+$997.5K
MAPLIGHT THERAPEUTICS INC0685,852+685,852$0$24.58M0.46%+$24.58M
KARDIGAN INC0900,000+900,000$0$21.46M0.40%+$21.46M
LEXEO THERAPEUTICS INC6,184,1344,175,382-2,008,752$35.50M$19.44M0.36%-$16.06M
EDITAS MEDICINE INC05,586,625+5,586,625$0$18.10M0.34%+$18.10M
INVENTIVA SA4,000,0004,000,0000$22.20M$15.12M0.28%-$7.08M
ABIVAX Société Anonyme(ABVX)772,4730-772,473$86.01M$0—-$86.01M
ARCELLX INC
COMMON STOCK
5,774,0160-5,774,016$662.97M$0—-$662.97M
BRIDGEBIO ONCOLOGY THERAPEUT868,2130-868,213$7.77M$0—-$7.77M
CENTESSA PHARMACEUTICALS PLC3,574,0480-3,574,048$141.96M$0—-$141.96M
Cytokinetics, Incorporated(CYTK)1,480,8570-1,480,857$97.60M$0—-$97.60M
KALARIS THERAPEUTICS INC700,0000-700,000$4.04M$0—-$4.04M
Maze Therapeutics, Inc.(MAZE)2,744,3990-2,744,399$81.92M$0—-$81.92M
Mirum Pharmaceuticals, Inc.(MIRM)625,0000-625,000$57.74M$0—-$57.74M
ORIC Pharmaceuticals, Inc.(ORIC)1,701,2170-1,701,217$21.55M$0—-$21.55M
Scholar Rock Holding Corporation(SRRK)1,226,0800-1,226,080$60.27M$0—-$60.27M
STRUCTURE THERAPEUTICS INC545,2870-545,287$26.28M$0—-$26.28M
TERNS PHARMACEUTICALS INC2,216,4990-2,216,499$116.85M$0—-$116.85M
UroGen Pharma Ltd.(URGN)1,703,9490-1,703,949$30.64M$0—-$30.64M
Veradermics, Incorporated(MANE)525,0000-525,000$33.15M$0—-$33.15M
Page 1 of 1
Paradigm Biocapital Advisors LP — 13F Holdings — Q2 2026 | TickerTrail